84 related articles for article (PubMed ID: 19010840)
1. Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.
Bearfoot JL; Choong DY; Gorringe KL; Campbell IG
Clin Cancer Res; 2008 Nov; 14(22):7246-50. PubMed ID: 19010840
[TBL] [Abstract][Full Text] [Related]
2. Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer.
Van Trappen PO; Cullup T; Troke R; Swann D; Shepherd JH; Jacobs IJ; Gayther SA; Mein CA
Gynecol Oncol; 2007 Jan; 104(1):129-33. PubMed ID: 16942794
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
Yang J; Zhou F; Xu T; Deng H; Ge YY; Zhang C; Li J; Zhuang SM
Mutat Res; 2008 Feb; 638(1-2):205-9. PubMed ID: 17900631
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.
Campbell IG; Phillips WA; Choong DY
Clin Cancer Res; 2006 Jun; 12(12):3713-5. PubMed ID: 16778097
[TBL] [Abstract][Full Text] [Related]
6. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
7. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in ovarian cancer biology and therapy resistance.
van Jaarsveld MT; Helleman J; Berns EM; Wiemer EA
Int J Biochem Cell Biol; 2010 Aug; 42(8):1282-90. PubMed ID: 20083225
[TBL] [Abstract][Full Text] [Related]
9. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
10. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
11. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
12. Germline mutation of microRNA-125a is associated with breast cancer.
Li W; Duan R; Kooy F; Sherman SL; Zhou W; Jin P
J Med Genet; 2009 May; 46(5):358-60. PubMed ID: 19411564
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
15. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions.
Selcuklu SD; Yakicier MC; Erson AE
Cancer Genet Cytogenet; 2009 Feb; 189(1):15-23. PubMed ID: 19167607
[TBL] [Abstract][Full Text] [Related]
16. The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.
Despierre E; Lambrechts D; Neven P; Amant F; Lambrechts S; Vergote I
Gynecol Oncol; 2010 May; 117(2):358-65. PubMed ID: 20207398
[TBL] [Abstract][Full Text] [Related]
17. Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
Bentivegna S; Zheng J; Namsaraev E; Carlton VE; Pavlicek A; Moorhead M; Siddiqui F; Wang Z; Lee L; Ireland JS; Suyenaga K; Willis TD; Faham M; Seymour AB
Hum Mutat; 2008 Mar; 29(3):441-50. PubMed ID: 18186519
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
[TBL] [Abstract][Full Text] [Related]
19. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
Balakrishnan A; Bleeker FE; Lamba S; Rodolfo M; Daniotti M; Scarpa A; van Tilborg AA; Leenstra S; Zanon C; Bardelli A
Cancer Res; 2007 Apr; 67(8):3545-50. PubMed ID: 17440062
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer.
Swisher EM; Wollan M; Mahtani SM; Willner JB; Garcia R; Goff BA; King MC
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):662-7. PubMed ID: 16150257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
